Spironolactone ameliorates the endothelial dysfunction induced by visceral adipose tissue in obese female mice exposed to early life stress Authors: Nermin Ahmed, Meghan B. Turner, Jacqueline R. Leachman, Anna Seebold, Cole Cincinelli, Carolina Dalmasso, Analia S. Loria Published: 2026 ABSTRACT Previously, we have shown that female mice exposed to maternal separation and early weaning (MSEW), a mouse model of early life stress, display an exacerbated obesogenic response to a hypercaloric diet via a mechanism that most likely involves the mineralocorticoid receptor (MR). This study investigated whether perivascular adipose tissue-derived factors influence vascular endothelial function in obese female MSEW mice using the MR antagonist spironolactone in vivo. C57BL/6J mice pups were subjected to MSEW or control rearing. At weaning, female mice were placed on a high-fat diet for 20 wk and treated with vehicle or spironolactone (100 mg/kg/day) for two additional weeks. Mice were then euthanized, thoracic aortas were isolated and cleaned to assess endothelial function in aortic rings preincubated with either DMEM, or explant media from either perivascular adipose tissue (PVAT) or mesenteric adipose tissue (MESAT) incubated in DMEM (2 h, 37°C). MSEW did not influence acetylcholine (ACh)-induced maximal relaxation in isolated rings of vehicle-treated mice preincubated with DMEM or PVAT explant media. However, preincubation with MESAT explant media impaired relaxation only in MSEW mice. Overall, spironolactone improved vascular relaxation in isolated rings preincubated with either type of adipose tissue explant; however, this effect was enhanced in rings from MSEW mice preincubated with their MESAT explant media. Taken together, these findings suggest that MESAT-derived endocrine and inflammatory mediators promote endothelial dysfunction in obese female mice exposed to MSEW, whereas spironolactone ameliorates this effect. INTRODUCTION Adverse childhood experiences (ACEs), including physical and emotional traumas and household dysfunction that occur before adulthood, are a major determinant of long-term cardiometabolic health. These early stressors disrupt development and are strongly associated with increased disease burden and premature mortality (1–5). The seminal 1998 ACE study conducted within a large Health Maintenance Organization in San Diego first established robust links between childhood adversity and poor health outcomes, including depression, cancer, lung disease, skeletal fractures, and cardiometabolic-associated risks such as obesity, ischemic heart disease, and liver disease (1). Following studies have correlated the cumulative number of ACEs with increased adult body mass index (BMI) and insulin resistance later in life (6–10). Specifically, participants who experienced more than three ACEs had a 1.5- to 1.9-fold increased risk for severe obesity (BMI ≥ 35 kg/m2) in adulthood (1, 11), a major risk factor in the development of cardiovascular disease due to the deleterious effect of adipokines on the vascular endothelium (12, 13). Accordingly, ACEs have also been associated with increased blood pressure (14, 15), vascular endothelial dysfunction (16), vascular stiffness (17), and peripheral vascular resistance (18, 19). The cardiometabolic consequences of ACEs are not uniformly distributed across the population. Numerous clinical studies demonstrate that ACE exposures have a stronger and dose-dependent negative impact on BMI in women (20–23) and this effect is also stratified by race (23, 24). Accordingly, we analyzed the data from a cohort of over 22,000 individuals and reported that specific adverse experiences alter metabolic biomarkers with a unique signature depending on sex or race (23). Further investigation of these associations is critical for developing more effective preventive and personalized medical strategies to reduce health disparities. Rodent models of early life stress reflect patterns observed in human studies, highlighting their value in identifying potentially translational therapeutic targets. Specifically, our laboratory has shown that maternal separation and early weaning (MSEW) is a mouse model of neglect that, when combined with a high-fat diet (HFD) feeding, exacerbates visceral adipose tissue mass and circulating concentrations of aldosterone only in adult female offspring compared with normally reared female used as controls (25, 26). Notably, although MSEW did not influence circulating concentrations of corticosterone in obese female mice, we have reported that perigonadal adipose tissue, a type of visceral adipose tissue, produces and releases more corticosterone compared with control mice (27). The local glucocorticoid metabolism is regulated by the 11β-hydroxysteroid dehydrogenases (11β-HSDs). This enzyme primarily functions as a reductase, converting inactive cortisone to active corticosterone (or cortisol in humans) (28–30), whereas 11β-HSD2 acts as a dehydrogenase, converting active cortisol to inactive cortisone (30, 31). This process is important for regulating the balance between active and inactive glucocorticoid concentrations in tissues, thereby protecting the mineralocorticoid receptor (MR) from cortisol binding (30, 31). Consequently, we propose that MR overstimulation in visceral adipose tissue from MSEW mice may result from both increased circulating aldosterone and local corticosterone production. Consistent with this hypothesis, we have previously shown that chronic treatment with spironolactone, a nonspecific MR antagonist, resulted in a loss of adipose tissue mass in obese females exposed to MSEW, but not in their control counterparts (27). Nevertheless, whether increases in circulating aldosterone (or local corticosterone) and other adipose tissue-derived factors may contribute to inducing vascular dysfunction in obese female MSEW mice remains unknown. Despite a large body of studies showing that women display increased rates of stress-related comorbidities such as anxiety, depression, obesity, and ischemic heart disease associated with higher levels of plasma aldosterone (32–34), the underlying mechanism by which early life stress may lead to vascular dysfunction remains unexplored (10, 35–37). Therefore, we designed this study to test whether obese female MSEW mice display endothelial dysfunction in aortas with or without the influence of perivascular adipose tissue-derived factors, and whether any of these effects are mediated by MR. Consequently, we assessed the ex vivo acetylcholine (ACh)-induced relaxation in isolated aortas preincubated with clean explant media, or explant media from two different types of adipose tissue: aortic perivascular adipose tissue (PVAT) or mesenteric adipose tissue (MESAT), anatomically associated with conductance or resistance vessels, respectively. METHODS Animal Model The study, which followed ARRIVE 2.0 and the National Institutes of Health Guide for the Care and Use of Laboratory Animals guidelines, was approved and monitored by the IACUC at the University of Kentucky. MSEW was performed using C57BL/6 breeders given ad libitum access to food (2918 Teklad irradiated Global 18% Protein Rodent Diet) and water (Lexington city tap water treated by reverse osmosis), as previously reported (25). Animal rooms were maintained at 21 ± 2°C and kept on a 14:10 light:dark cycle. MSEW litter pups were separated from the dam for 4 h a day from postnatal days (PD) 2 to 5 and for 8 h a day from PD 6 to 16. Pups were weaned early on PD 17. Separation occurred at the same time of day, when the mother was removed from the cage, the pups were placed into a clean cage in a thermoregulated incubator (30 ± 1°C, 60% humidity). Normally reared litters served as controls and remained undisturbed with the dam until weaning at PD 21. To standardize maternal care and nutrition, litter size was culled to 6–8 pups. At weaning, mice were placed on a HFD (60% kcal from fat, Research Diets, New Brunswick, NJ) for 22 wk. Experimental Design After 20 wk of HFD, control and MSEW female mice were used for the study. Only healthy female offspring that completed the MSEW or control protocol and maintained expected body weights, growth, and activity were included. Females showing signs of illness or abnormal growth were excluded before randomization. Because blood pressure changes related to early life stress arise through sex-specific mechanisms, male littermates were used in other studies (38, 39). We used aortas and adipose tissue for ex vivo testing from mice used in a previously reported study (27). First, mice were single-housed to record the baseline water consumption for 3 days. Next, all mice were switched to the vehicle solution (2:1:1 ratio of water/Ora-Plus suspending vehicle/Ora-Sweet sugar-free flavored syrup vehicle, Perrigo Pharmaceutical Company, Allegan Michigan) for an additional 3 days to record liquid consumption as previously reported (27). A vehicle solution was necessary to ensure the dissolution of spironolactone in drinking water. Mice were randomized to receive either vehicle or spironolactone (100 mg/kg/day, ad libitum) treatment for 2 wk. No attrition occurred during the treatment period; all randomized females completed the protocol and were included in the final analyses. Study personnel conducting data collection and end point analyses were blinded to treatment groups to minimize bias. At the end of the experiment, mice were anesthetized using ketamine/xylazine. Blood was collected by cardiac puncture, and the aorta was carefully dissected for endothelial function studies. Adipose tissue depots were harvested and used for tissue explants incubations or snap-frozen for gene expression analysis. Endothelial Function Aortas were dissected surgically, carefully cleaned of PVAT under the microscope, cut into 2-mm long rings, and mounted on a wire myograph (DMT, Aarhus, Denmark). Endothelial function was assessed with cumulative concentration-response (CCR) curves to acetylcholine (ACh, 10−4 M/L to 10−9 M/L), as previously reported (40). After the first relaxation curve, rings from the same mice were randomized to incubation in either DMEM or adipose tissue explant media for 30 min, followed by repetition of the ACh-induced relaxation CCR curve. Each mouse aortic rings received their own PVAT or MESAT explant media. Endothelium-independent relaxation was analyzed with a CCR curve to sodium nitroprusside (SNP, ACh, 10−4 M/L to 10−12). Relaxation curves were performed on pre-constricted vessels with serotonin (5-HT 0.1–1 μmol/L) and relaxation was expressed as a percent of the constriction. Adipose Tissue Explants Media Collection for Vascular Function Studies To standardize the experimental conditions across all groups, we first weighed comparable amounts of PVAT and MESAT adipose tissue (~40 mg for each group) to eliminate any mass effect due to the increased adiposity displayed by female MSEW mice fed a HFD (25–27, 41). Tissue explants were incubated (2 h at 37°C) in 200 μL of Dulbecco’s modified Eagle’s medium (DMEM) containing 2% of free fatty acid-bovine serum albumin (BSA) (27). MESAT Explants Media Collection for Hormone Measurement Adipose tissue was weighed (~100 mg for all groups) and incubated for 2 h in DMEM, as described earlier. After 2 h, explant media was separated, snap frozen, and stored at −80°C. For the measurement of aldosterone and corticosterone, media were extracted following the manufacturer’s instructions, and the pellet reconstituted in ELISA buffer (Item No. 501320 and 501090, respectively, Cayman, Ann Arbor, MI). All values were normalized by mg of explant tissue. Gene Expression RNA was isolated from PVAT and MESAT using the Aurum Total RNA Mini Kit (Bio-Rad Laboratories, RRID: SCR_008426), Hercules, CA) (27). One microgram of RNA was used in a reverse transcriptase reaction with iScript Reverse Transcriptase (Bio-Rad, Cat. No. 1708891) to prepare cDNA. cDNA (25 ng) was used in the qRT-PCR reactions. The reaction protocol was as follows: 1) 94°C 5 min; 2) 94°C 30 s; 3) 56°C 30 s; 4) 72°C 45 s; 5) repeat steps 2–4 for 40 cycles; 6) 72°C 10 min. We have used the following Taqman primers: 11bHSD1 (Mm00476182_m1), 11bHSD2 (Mm01251104_m1), IL-6 (Mm00446190_m1), IL-17a (Mm00439619_m1), Leptin (Mn00434759_m1), tumoral necrosis factor (TNF) (Mm00443258_m1), transforming growth factor (TGF)β (Mm01178820_m1), free fatty acid binding protein 4 (FABP4) (Mn00445878_m1), and the housekeeper gene (HpRT) (Mm03024075_m1). Statistical Analysis All data are expressed as means ± SE. Power calculations were based on prior studies using this model and similar outcome measures. Assuming a standard deviation of 9.65 U, a sample size of six (6) mice per group provided 80% power to detect a between-group difference of 7.24 U at an α level of 0.05 using a paired t test framework. At study end point, body weight, fat pads, plasma hormones, explant media hormones, tissue media gene expression, and endothelial function were visualized using plots and summary statistics to evaluate distributional assumptions and homogeneity of variance. These outcomes were analyzed using two-way ANOVA, with early life stress (MSEW) and spironolactone treatment as fixed factors. When appropriate, post hoc comparisons were performed to assess group differences. All statistical analyses were conducted using GraphPad Prism 10 (v.10.6.0, RRID:SCR_002798, Boston, MA). RESULTS Maximal Relaxation in Vehicle- and Spironolactone-Treated Mice Is Not Influenced by MSEW Aortas preincubated with DMEM displayed similar relaxation in female MSEW and control mice fed an HFD treated with vehicle for 2 wk (Fig. 1A). There was a similar maximal relaxation between rings from control and MSEW mice (Fig. 1B, top). Furthermore, the logEC50 values in isolated rings preincubated with DMEM were also comparable between groups (Fig. 1B, bottom). MSEW Increases PVAT and MESAT Weight PVAT (Fig. 1C) and MESAT (Fig. 1D) tissue weights were increased in MSEW mice regardless of the spironolactone treatment. Explant tissues were normalized to ~40 mg of PVAT (Fig. 1E) or MESAT (Fig. 1F) in each group. Body weight and total body adiposity are displayed in Supplemental Table S1. As previously reported, increases in body adiposity in MSEW mice fed a HFD were significantly reduced by the spironolactone treatment. Spironolactone Treatment Improved Endothelial Function in Rings Preincubated with PVAT Explant Media Regardless of MSEW Aortas preincubated with PVAT explant media displayed similar maximal relaxation in female MSEW and control mice, whereas spironolactone treatment improved endothelial function in both groups (Fig. 2A). Although spironolactone increased maximal relaxation in both groups (Fig. 2B), the logEC50 values in isolated rings preincubated with PVAT were comparable between control and MSEW (Fig. 2C). Spironolactone Treatment Ameliorated the Endothelial Dysfunction in Rings from MSEW Mice Preincubated with MESAT Explant Media MSEW impaired ACh-induced relaxation in rings preincubated with MESAT explant media. However, spironolactone treatment reduced this effect (Fig. 2D). Overall, spironolactone treatment improved maximal relaxation only in rings from MSEW mice preincubated with MESAT (Fig. 2E). No significant effects of spironolactone treatment in logEC50 were found in isolated rings preincubated with MESAT from either control or MSEW mice (Fig. 2F). Validation of the Endothelial Function Approach to Assess the Effect of Adipose Tissue-Derived Factors We confirmed that serotonin-induced pre-constriction was similar across all groups following preincubations with DMEM, PVAT, and MESAT explant media (Supplemental Fig. S1). In addition, we verified that there were no significant differences in relaxation between the first and second dose-response curves within the same aortic ring (Supplemental Fig. S1B), ensuring endothelial integrity and validating any significant differences in the maximal relaxation between DMEM and tissue explant preincubation. Finally, we showed that SNP-induced maximal relaxation was similar between vehicle and spironolactone-treated rings in both control and MSEW mice (Supplemental Fig. S1C). MESAT-Derived Endocrine and Inflammatory Factors Are Increased in Female MSEW Mice To identify potential MESAT-derived factors impairing endothelial function, we measured explant media hormones that typically bind to the MR. MESAT-derived aldosterone concentrations were similar in control and MSEW explant media, whereas spironolactone treatment similarly increased aldosterone concentrations in MESAT explant media in both groups (Fig. 3A). Conversely, corticosterone was increased in explant media from MSEW mice treated with vehicle; however, spironolactone treatment did not influence these concentrations in either group (Fig. 3B). MESAT 11βHSD1 mRNA expression was similar between groups (Fig. 3C); however, 11βHSD2 RNA expression was increased in explant tissue from MSEW mice treated with spironolactone (Fig. 3D). In addition to hormones, we measured the expression of two key citokines that are modulated by MR signaling. Specifically, MSEW increased IL-6 (Fig. 4A) and IL-17 (Fig. 4B) mRNA expression in MESAT, whereas spironolactone precluded this effect in the expression of IL-17 only. Furthermore, leptin expression was not different in MESAT tissue from control and MSEW mice, and spironolactone treatment reduced mRNA abundance similarly in both groups (Fig. 4C). Overall, both MSEW and spironolactone treatment showed a main effect to reduce TGFβ mRNA expression in MESAT (Fig. 4D). Conversely, MSEW was associated with an overall reduction in TNFα mRNA abundance in MESAT (Fig. 4E), whereas FBP4 was increased regardless of the spironolactone treatment (Fig. 4F). Spironolactone Lowered Circulating IL-17 Concentration in MSEW Mice Circulating concentrations of IL-6 and IL-17 were increased in obese MSEW mice (Fig. 5). Spironolactone treatment did not influence plasma IL-6 (Fig. 5A); however, blocking the MR reduced plasma IL-17 in MSEW mice (Fig. 5B). DISCUSSION This study identifies specific visceral adipose tissue-derived proinflammatory factors as a potential contributor to endothelial dysfunction in obese female mice exposed to early life stress. Furthermore, we demonstrate that factors released from MESAT, not PVAT, impair endothelial-dependent relaxation in MSEW mice, and that the chronic pharmacological blockade of MR with spironolactone ameliorated this dysfunction. Taken together, these findings suggest that visceral adipose tissue-derived factors, particularly IL-17, may induce endothelial dysfunction in obese female mice exposed to MSEW, mediated, at least in part, by the MR receptor. We have previously reported that female mice exposed to MSEW display an exacerbated obesogenic response to a chronic HFD, including greater glucose intolerance, visceral adipose tissue expansion, and higher blood pressure compared with control counterparts (25, 26). Interestingly, chronic treatment with spironolactone induced a greater fat mass loss in female MSEW mice than in controls, suggesting an MR-dependent mechanism (27). Building on these findings, the present study was designed to investigate whether two metabolically distinct adipose tissue depots have specific effects modulating endothelial function in MSEW mice. Specifically, we examined the effect of PVAT and MESAT explant media on the maximal relaxation response of thoracic aortas from MSEW and control female mice. The outcomes of our study indicate that the expression and secretion of endocrine and proinflammatory mediators, could play a significant role in impairing endothelial function in female MSEW mice fed a HFD. This data suggests that MSEW exacerbates the proinflammatory signaling in visceral fat as potential mechanism shaping the pathophysiology of cardiovascular disease in females (42, 43). Our findings also suggest that visceral adipose tissue surrounding small mesenteric arteries could play a critical role in promoting peripheral vascular resistance in this model. We have previously reported that female MSEW mice fed an HFD show increased corticosterone production in peri-ovarian white adipose tissue, a different type of visceral adipose tissue used in the current study (27). Here, we determined that corticosterone production is increased in MESAT from female MSEW mice compared with controls as well. Although spironolactone treatment did not influence corticosterone concentrations in either group, increased glucocorticoids levels could contribute to the MR stimulation in endothelial cells of isolated aortic rings from female MSEW mice. Notably, corticosterone and other glucocorticosteroids can paradoxically promote IL-17 production (44). This study shows that in MSEW mice, MESAT, a visceral fat depot which surrounds resistance vessels of the mesenteric vascular beds, show increased corticosterone and IL-17 production. Elevations in circulating IL-17 were abolished by spironolactone treatment, in parallel with the improvements found in vascular reactivity. Several studies have implicated IL-17 in the pathology of vascular endothelial function, specifically via activation of Rho-kinase and impaired NO signaling (45, 46). IL-6, also increased in MESAT, is a synergistic cytokine that promotes the differentiation of IL-17-producing TH17 cells in concert with TFGβ, whereas its own production is stimulated by IL-17 (47). Yet, we found a decrease in MESAT TGFβ expression in MSEW mice. In addition, TNFα, a master proinflammatory cytokine, has been demonstrated to have a direct negative effect on vascular endothelial function, which is synergistically enhanced by IL-17 (48–50). Thus, even though TNFα expression was not increased by MSEW in MESAT of vehicle-treated mice, it was reduced by spironolactone treatment only in MSEW mice. Taken together, we propose that MSEW increases local expression of IL-17 as well as IL-6 and TNFα that work synergistically to impair vascular endothelial function in these mice. MR antagonism negatively modulates these cytokines only in MSEW mice, improving vascular function in the settings of obesity. From a technical standpoint, it is important to note that we performed a first ACh-induced relaxation curve to ensure that all aortic rings treated with DMEM or explant media display a comparable relaxation capacity. No functional differences in precontraction levels or maximal relaxation were found between consecutive curves. In addition, SNP dose-response curves indicate that an endothelium-dependent mechanism mediates the impaired maximal relaxation in MSEW mice. One limitation of this study is the assessment of endothelial function in a conductance vessel exposed to an explant media that is not in close contact with the vascular wall, unlike PVAT. Previously, we reported that circulating corticosterone concentrations were similar in control and MSEW female mice fed a HFD (27). However, the current findings support the hypothesis that MESAT-derived factors could significantly impact resistance vessels in the mesenteric vascular bed. Our findings provide valuable insights for future studies testing the mechanisms by which MSEW may affect microvascular function and peripheral vascular resistance, potentially explaining the exacerbated increases in blood pressure in female MSEW mice fed a HFD previously reported using this model. Another limitation is the use of a nonspecific MR antagonist. Spironolactone is used as an MR antagonist in patients with hypertension, cardiovascular disease, and acne (51–53) due to their ability to block the androgen or the progesterone receptors (54). The use of a specific MR antagonist, such as eplerenone, or a fat-specific MR knock-out would elucidate the contribution of MR signaling in the production of visceral adipose tissue-derived proinflammatory factors. Whether MSEW influences the MR expression in endothelial cells remains to be determined, and further investigation is needed to fully understand the mechanisms underlying the observed differences in vascular relaxation. Prior work from Belin de Chantemele’s laboratory has shown that endothelial dysfunction in obese and diabetic female mice is strongly influenced by MR signaling (55, 56). Endothelial MR expression is higher in obese females compared with males, contributing to sex-specific differences in obesity-induced endothelial dysfunction by promoting endothelial stiffness and impairing endothelium-dependent relaxation in both conduit and resistance arteries (57). Leptin is a key activator of the aldosterone-MR axis in adrenal glands and plays a major role in cardiovascular damage in female obesity. Along these lines, obese MSEW female mice display higher circulating angiotensin II (41) and leptin (26), hormones known to increase aldosterone production in the adrenal glands (27). These findings highlight the therapeutic potential of MR antagonists in preventing cardiovascular dysfunction mediated by MR signaling in endothelial, smooth muscle cells and perivascular adipose tissue, particularly in vulnerable populations such as those exposed to early life stress. Finally, although we normalized the amount of tissue used for explants, we observed greater effects of MESAT explant media from MSEW mice. This data supports the notion that expanded visceral adipose tissue in MSEW mice could amplify the detrimental effects of MESAT-derived factors on vascular function. Of note, the power analysis was not specifically designed to detect interaction effects within the two-way ANOVA framework, limiting the interpretation of the reported outcomes. Despite the sample size was sufficient to detect main effects based on prior studies, this study may be under-powered to fully resolve interactions between MSEW and spironolactone treatment. Therefore, interaction results should be interpreted with caution. Thus, future studies with larger sample sizes will be needed to confirm and further address the current findings. In conclusion, our study demonstrates that obese female mice exposed to MSEW display an exacerbated production of proinflammatory mediators in visceral adipose tissue, most likely mediated, at least in part, by a mechanism involving MR signaling. Forthcoming studies assessing the impact of these factors in the mesenteric bed microvascular endothelium may elucidate the contribution of this pathway to the exacerbated obesity-induced hypertension shown by female mice exposed to early life stress. Clinical Perspective Women exposed to adverse childhood experiences face disproportionately higher risks of obesity-related cardiovascular disease; however, the biological mechanisms underlying this vulnerability remain poorly understood. This study identifies visceral adipose tissue-derived inflammatory signaling and MR activation, particularly involving IL-17, as a potential mechanistic link between early life stress and endothelial dysfunction. These findings highlight the potential for MR antagonists and adipose-targeted anti-inflammatory strategies to mitigate the sex-specific cardiovascular risk in populations exposed to early life stress, supporting the development of personalized medicine approaches aimed at reducing cardiometabolic health disparities. Supplementary Material Supplemental Fig. S1 and Supplemental Table S1: https://doi.org/10.6084/m9.figshare.30631049.